Clinical Trial Update: Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update showing safety and preliminary efficacy of S-8184 as second-line therapy for stage III/IV ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• S-8184

Snippet

Sponsor: Achieve Life Sciences | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED